Navigation Links
Sigma-Aldrich Elects Michael Marberry As Director
Date:9/19/2012

ST. LOUIS, Sept. 19, 2012 /PRNewswire/ -- The Board of Directors of Sigma-Aldrich Corporation (NASDAQ: SIAL) has elected Michael Marberry as a Director of the Company. Mr. Marberry (age 54) is President and CEO of J.M. Huber Corporation, a diversified, multinational supplier of engineered materials, natural resources and technology-based services to customers spanning many industries from paper and energy to plastics and construction.

In announcing Mr. Marberry's election to the Board, Rakesh Sachdev, President and CEO of Sigma-Aldrich, said, "We are extremely pleased to have Michael Marberry join our Board.  His broad background and international experience in leading a successful global company and in expanding into applied chemical and industrial markets will help Sigma-Aldrich in strategic efforts to enhance its leadership position in Life Science and High Technology."

About Sigma-Aldrich:  Sigma-Aldrich is a leading Life Science and High Technology company.  Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing.  The Company has customers in life science companies, university and government institutions, hospitals and in industry.  Over one million scientists and technologists use its products.  Sigma-Aldrich operates in 38 countries and has 9,100 employees providing excellent service worldwide.  The Company is committed to accelerating customer success through innovation and leadership in Life Science, High Technology and Service.  For more information about Sigma-Aldrich, please visit its award winning web site at www.sigma-aldrich.com.


'/>"/>
SOURCE Sigma-Aldrich
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich to Acquire BioReliance; Extending Its Reach into Biopharmaceutical Testing and Services
2. Sigma-Aldrich Opens New Wuxi Packaging and Quality Control Facilities to Enhance Capabilities Serving China and Asia-Pacific Region
3. Sigma-Aldrich Corporation Announces New Credit Facility
4. InspireMD Elects Sol J. Barer, Ph.D. Chairman of the Board of Directors
5. Islet Sciences, Inc. Selects NeoStems Manufacturing Subsidiary Progenitor Cell Therapy for Product Manufacturing
6. Netsmart Selects Overland Park, Kansas, for New Office
7. Pharmaceutical Consortium Selects BioFortis Software to Manage Collaborative Clinical Data and Biobanking Activities
8. Avaxia Biologics Elects Christopher Kiritsy to its Board of Directors
9. Maine Center for Creativity Selects Glenn Close and David Shaw to Receive Inaugural Maine Creative Industry Award
10. Aesthetics Pharmaceutical Company Selects 360 Vantage Closed Loop Marketing Solution for Apple iPad
11. Eaton Apothecary Selects Predictive Acquisition Cost (PAC) Drug Price Type
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... July 20, 2017 , ... ... of life, today announced its full advisory board. The board comprises leaders spanning ... of James Crooks, PhD, former VP of Engineering, to Chief Technology Officer. Crooks ...
(Date:7/20/2017)... DENVER and PLYMOUTH, Minn., July 20, 2017 ... LLC , a personalized genetic evaluations company, today ... under their partnership investigating a genetic mutation implicated ... to extend the partnership for a second case ... Last year, the KCNQ2 Cure Alliance and Pairnomix ...
(Date:7/18/2017)... ... July 18, 2017 , ... Nanomedical Diagnostics, a cutting-edge ... the launch of a new NTA biosensor chip for use with its label-free ... kinetics of polyhistidine-tagged (His-tagged) molecules quickly and reliably. , “Recombinant proteins are ...
(Date:7/18/2017)... ... ... G-CON today announced that it has received Notices of ... 14/858,857 and 13/669,785 both entitled Modular, Self-Contained, Mobile Clean Room. The U.S. Patent ... G-CON’s R&D investments and validate the G-CON platform as a novel way to ...
Breaking Biology Technology:
(Date:4/5/2017)... KEY FINDINGS The global market ... CAGR of 25.76% during the forecast period of 2017-2025. ... for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is segmented ... The stem cell market of the product is segmented ...
(Date:3/30/2017)... HONG KONG , March 30, 2017 ... developed a system for three-dimensional (3D) fingerprint identification by adopting ground ... technology into a new realm of speed and accuracy for use ... applications at an affordable cost. ... ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health ... and Management Systems Society (HIMSS) Analytics for achieving ... Adoption Model sm . In addition, CHS previously ... U.S. hospitals using an electronic medical record (EMR). ... its high level of EMR usage in an ...
Breaking Biology News(10 mins):